Ítem
Solo Metadatos

The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel

Mostrar el registro sencillo de la publicación
dc.creatorSantos Garcia J.B.spa
dc.creatorLech O.spa
dc.creatorCampos Kraychete D.spa
dc.creatorRico M.A.spa
dc.creatorHernández-Castro J.J.spa
dc.creatorColimon F.spa
dc.creatorGuerrero C.spa
dc.creatorSempértegui Gallegos M.spa
dc.creatorLara-Solares A.spa
dc.creatorFlores Cantisani J.A.spa
dc.creatorAmescua-Garcia C.spa
dc.creatorGuillén Núñez M.D.R.spa
dc.creatorBerenguel Cook M.D.R.spa
dc.creatorJreige Iskandar A.spa
dc.creatorBonilla Sierra P.spa
dc.date.accessioned2020-05-26T00:05:40Z
dc.date.available2020-05-26T00:05:40Z
dc.date.created2017spa
dc.description.abstractObjective: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol’s role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. Methods: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. Results: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol’s high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics–mainly controlled drugs (classical opioids)–is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. Conclusions: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients. © 2017 Informa UK Limited, trading as Taylor and Francis Group.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1080/03007995.2017.1354821
dc.identifier.issn3007995
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23815
dc.language.isoengspa
dc.publisherTaylor and Francis Ltdspa
dc.relation.citationEndPage1621
dc.relation.citationIssueNo. 9
dc.relation.citationStartPage1615
dc.relation.citationTitleCurrent Medical Research and Opinion
dc.relation.citationVolumeVol. 33
dc.relation.ispartofCurrent Medical Research and Opinion, ISSN:3007995, Vol.33, No.9 (2017); pp. 1615-1621spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85027699710&doi=10.1080%2f03007995.2017.1354821&partnerID=40&md5=6d93f117df15722fb10b85cc88e5fa56spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordNonsteroid antiinflammatory agentspa
dc.subject.keywordOpiatespa
dc.subject.keywordTramadolspa
dc.subject.keywordNarcotic analgesic agentspa
dc.subject.keywordNonsteroid antiinflammatory agentspa
dc.subject.keywordTramadolspa
dc.subject.keywordCancer painspa
dc.subject.keywordCardiovascular diseasespa
dc.subject.keywordCentral americaspa
dc.subject.keywordChronic painspa
dc.subject.keywordConstipationspa
dc.subject.keywordDisease severityspa
dc.subject.keywordDrug abusespa
dc.subject.keywordDrug dependencespa
dc.subject.keywordDrug efficacyspa
dc.subject.keywordDrug indicationspa
dc.subject.keywordDrug safetyspa
dc.subject.keywordDrug tolerabilityspa
dc.subject.keywordFibromyalgiaspa
dc.subject.keywordGastrointestinal symptomspa
dc.subject.keywordHealth care qualityspa
dc.subject.keywordHumanspa
dc.subject.keywordMusculoskeletal painspa
dc.subject.keywordNauseaspa
dc.subject.keywordNephrotoxicityspa
dc.subject.keywordPainspa
dc.subject.keywordPostoperative painspa
dc.subject.keywordPosttraumatic painspa
dc.subject.keywordRandomized controlled trial (topic)spa
dc.subject.keywordRespiration depressionspa
dc.subject.keywordReviewspa
dc.subject.keywordSide effectspa
dc.subject.keywordSouth americaspa
dc.subject.keywordVomitingspa
dc.subject.keywordAgedspa
dc.subject.keywordAnalgesiaspa
dc.subject.keywordSouth and central americaspa
dc.subject.keywordAgedspa
dc.subject.keywordAnalgesicseng
dc.subject.keywordAnti-inflammatory agentseng
dc.subject.keywordCancer painspa
dc.subject.keywordChronic painspa
dc.subject.keywordHumansspa
dc.subject.keywordLatin americaspa
dc.subject.keywordPain managementspa
dc.subject.keywordTramadolspa
dc.subject.keywordAbusespa
dc.subject.keywordLatin americaspa
dc.subject.keywordPain managementspa
dc.subject.keywordPrescription controlspa
dc.subject.keywordTramadolspa
dc.titleThe role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panelspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos